Overview of the Results of Treating Carcinoid Crisis Without Perioperative Octreotide

Clinical 72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
November 5, 2021↗ source

Pharmacy Times video interview with Rodney Pommier, MD, FACS (Oregon Health & Science University) on his 2021 NANETS symposium presentation of a prospective study managing carcinoid crisis without perioperative octreotide. The piece reports surgical-outcome data challenging the routine prophylactic octreotide bolus before carcinoid surgery.

Related peptides

We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.